| Date | Title | | | 05/09/13 | MannKind Corporation Reports 2013 First Quarter Financial Results| - Conference Call to Begin Today at 5:00 P.M. EDT -
VALENCIA, Calif.--(BUSINESS WIRE)--May. 9, 2013--
MannKind Corporation (Nasdaq: MNKD) today reported financial
results for the first quarter ended March 31, 2013.
For the first quarter of 2013, total operating expenses were $36.4
million, compared to $33.9 million for the first quarter of 2012, an
increase of $2.5 million. Research and development (R&D) expenses were
$26.4 million... |
|  | | 05/08/13 | MannKind to Present at Bank of America Merrill Lynch 2013 Health Care Conference| VALENCIA, Calif.--(BUSINESS WIRE)--May. 8, 2013--
MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing
and commercializing treatments for diabetes, announced today that it
will present at the Bank of America Merrill Lynch 2013 Health Care
Conference on Wednesday, May 15, 2013 at 1:40 pm Pacific Time at the
Encore at the Wynn Hotel in Las Vegas, Nevada.
Interested parties can access a link to the live webcast of the
prese... |
| | | 05/02/13 | MannKind Corporation to Hold 2013 First Quarter Financial Results Conference Call on May 9, 2013| VALENCIA, Calif.--(BUSINESS WIRE)--May. 2, 2013--
MannKind Corporation (Nasdaq: MNKD) will release its 2013 first
quarter financial results on Thursday, May 9, 2013 and its management
will host a conference call to discuss the first quarter financial
results and other Company developments at 5:00 PM (Eastern Time) on May
9, 2013.
Presenting from the Company will be its Chairman and Chief Executive
Officer, Alfred Mann, President and Chief ... |
| | | 02/26/13 | MannKind Corporation to Present at the Cowen and Company 33rd Annual Health Care Conference| VALENCIA, Calif.--(BUSINESS WIRE)--Feb. 26, 2013--
MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing
and commercializing treatments for diabetes and cancer, announced today
that it will present at the Cowen and Company 33rd Annual Health Care
Conference on March 5, 2013 at 10:40 AM (EST) at the Boston Marriott
Copley in Boston, Massachusetts.
Interested parties can access a link to the live webcast of the
presenta... |
| | | 02/11/13 | MannKind Corporation Reports 2012 Fourth Quarter and Full Year Financial Results|
- Conference Call to Begin Today at 5:00 PM ET -
VALENCIA, Calif.--(BUSINESS WIRE)--Feb. 11, 2013--
MannKind Corporation (Nasdaq: MNKD) today reported financial
results for the fourth quarter and year ended December 31, 2012.
For the fourth quarter of 2012, total operating expenses were $33.5
million, compared to $30.6 million for the same quarter of 2011, an
increase of $2.9 million. Research and development (R&D) expenses were
... |
| | | 02/04/13 | MannKind Corporation to Hold 2012 Fourth Quarter and Full Year Financial Results Conference Call on February 11, 2013| VALENCIA, Calif.--(BUSINESS WIRE)--Feb. 4, 2013--
MannKind Corporation (Nasdaq: MNKD) will release its 2012 fourth
quarter and full year financial results on Monday, February 11, 2013 and
its management will host a conference call to discuss the fourth quarter
and full year financial results and other Company developments at 5:00
PM (Eastern Time) on February 11, 2013.
Presenting from the Company will be its Chairman and Chief Executive
... |
| | | 01/03/13 | MannKind Corporation to Present at The 31st Annual J.P. Morgan Healthcare Conference| VALENCIA, Calif.--(BUSINESS WIRE)--Jan. 3, 2013--
MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing
and commercializing treatments for diabetes and cancer, announced today
that it will present at The 31st Annual J.P. Morgan Healthcare
Conference on Thursday, January 10, 2013 at 8:00 AM (PST) at St. Francis
Hotel in San Francisco, California.
Interested parties can access a link to the live webcast of the
presentat... |
| |
|
